Page 1 of 7

Pharma Sector Analysis India

Continues for 6 more pages »
Read full document

Pharma Sector Analysis India

Page 1 of 7
Indian Pharmaceutical Sector Analysis

Contents:
* Introduction
* Market Size & Growth Rates
* Market Segmentation
* Key Players in Pharma Industry
* Market Drivers
* Challenges for Pharma Industry
* SWOT Analysis
* References

Introduction
Indian Pharmaceutical Industry is one of the success stories of modern India. The wide ranging capabilities in the complex field of drug manufacture & technology has established India as one of the major producer of the Pharmaceuticals worldwide. De-licensing of the pharmaceutical industry gave freedom to Indian Pharma manufacturers to produce any drug without Industrial licensing. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 12 billion, growing at about 12-13 percent annually. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. The industry is mostly based on allopathic medicines. There are about 250 large units and about 20000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations. The allopathic medicine industry consists of big players like Dr. Reddy’s, GSK, Pfizer, Ranbaxy and a lot of smaller players. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on...